Attenuation by nimodipine of amitriptyline-induced avoidance impairment in mice

Pharmacology Biochemistry and Behavior

Volumn 62, Issue 4, 1999, Pages 613-618

  Sansone, Mario ^a   Battaglia, Mario ^a   Pavone, Flaminia ^a  

^a CNR   (Italy)

Author keywords

Amitriptyline; Antidepressants; Avoidance behavior; Mice; Nimodipine; Psychomotor disturbances

Indexed keywords

AMITRIPTYLINE; CHLORPROMAZINE; NIMODIPINE;

ANIMAL EXPERIMENT; ARTICLE; AVOIDANCE BEHAVIOR; CONTROLLED STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PSYCHOMOTOR DISORDER;

AMITRIPTYLINE; ANIMALS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; ANTIPSYCHOTIC AGENTS; AVOIDANCE LEARNING; CALCIUM CHANNEL BLOCKERS; CHLORPROMAZINE; MALE; MICE; MICE, INBRED DBA; MOTOR ACTIVITY; NIMODIPINE; PSYCHOMOTOR PERFORMANCE;

EID: 0032988021     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(98)00202-0     Document Type: Article

References (36)

1. Amado-Boccara I., Gougoulis N., Poirier Littré M.F., Galinowski A., Loo H. Effects of antidepressants on cognitive functions. A review Neurosci. Biobehav. Rev. 19:1993;469-473.
2. Archer T., Ögren S.O., Johansson G., Ross S.B. The effect of acute zimeldine and alaproclate administation on the acquisition of two-way active avoidance. Comparison with other antidepressant agents, test of selectivity and sub-chronic studies Psychopharmacology (Berlin). 84:1984;188-195.
3. Beninger R.J., Mason S.T., Phillips A.G., Fibiger H.C. The use of conditioned suppression to evaluate the nature of neuroleptic-induced avoidance deficits. J. Pharmacol. Exp. Ther. 213:1980;623-627.
4. Bovet D., Bovet-Nitti F., Oliverio A. Short and long term memory in two inbred strains of mice. Life Sci. 5:1966;415-420.
5. Bovet D., Bovet-Nitti F., Oliverio A. Genetic aspects of learning and memory in mice. Science. 163:1969;139-149.
6. Cook L., Davidson A.B. Behavioral pharmacology. Animal models involving aversive control of behavior Lipton M.A., DiMascio A., Killam K.F. Psychopharmacology. A generation of progress:1978;563-567 Raven Press, New York.
7. De Feudis F.V. Interaction of calcium antagonists with neurotransmitter receptors and neurotransmitter uptake processes - Overview. Drugs Today. 23:1987;347-361.
8. Fairweather D.B., Ashford J., Hindmarch I. Effects of fluvoxamine and dothiepin on psychomotor abilities in healthy volunteers. Pharmacol. Biochem. Behav. 53:1996;265-269.
9. Finger S., Green L., Tarnoff M.E., Mortman K.D., Andersen A. Nimodipine enhances new learning after hippocampal damage. Exp. Neurol. 109:1990;279-285.
10. Freeman S.E., Dawson R.M. Tacrine. A pharmacological review Prog. Neurobiol. 36:1991;257-277.
11. Gaggi R., Gianni A.M. Effects of calcium antagonists on biogenic amines in discrete brain areas. Eur. J. Pharmacol. 181:1990;187-197.
12. Hauber W., Schmidt W.J. The NMDA antagonist dizocilpine (MK-801) reverses haloperidol-induced movement initiation deficits. Behav. Brain Res. 41:1990;161-166.
13. Izquierdo I. Nimodipine and the recovery of memory. Trends Pharmacol. Sci. 11:1990;309-310.
14. Loizzo A., Palazzesi S., Loizzo S., Battaglia M., Sansone M. Effects of low doses of physostigmine on avoidance learning and EEG in two strains of mice. Behav. Brain Res. 81:1996;155-161.
15. Mele A., Battaglia M., Sansone M. Reversal of chlorpromazine-induced avoidance depression by the N-methyl-d-aspartate antagonist, dizocilpine, in mice. J. Pharm. Pharmacol. 46:1994;390-392.
16. Nicholson C.D. Pharmacology of nootropics and metabolically active compounds in relation to their use in dementia. Psychopharmacology (Berlin). 101:1990;147-159.
17. Ogren S.O., Archer T. Effects of typical and atypical antipsychotic drugs on two-way active avoidance. Relationship to DA receptor blocking profile. Psychopharmacology (Berlin). 114:1994;383-391.
18. Oliverio A. Effects of mecamylamine on avoidance conditioning and maze learning of mice. J. Pharmacol. Exp. Ther. 154:1966;350-356.
19. Pavone F., Battaglia M., Sansone M. Nifedipine-morphine interaction. A further investigation on nociception and locomotor activity in mice J. Pharm. Pharmacol. 44:1992;773-776.
20. Pavone F., Battaglia M., Sansone M. Attenuation of cholinergic analgesia by nifedipine. Brain Res. 623:1993;308-310.
21. Pavone F., Battaglia M., Sansone M. Prevention of amitriptyline-induced avoidance impairment by tacrine in mice. Behav. Brain Res. 89:1997;229-236.
22. Pavone F., Capone F., Battaglia M., Sansone M. Shuttle-box avoidance learning in mice. Improvement by combined glucose and tacrine Neurobiol. Learn. Mem. 69:1998;204-210.
23. Posluns D. An analysis of chlorpromazine-induced suppression of the avoidance response. Psychopharmacologia. 3:1962;361-373.
24. Pucilowski O. Psychopharmacological properties of calcium channel inhibitors. Psychopharmacology (Berlin). 109:1992;12-29.
25. 2 dopamine receptors Psychopharmacology (Berlin). 113:1994;476-480.
26. Sandin M., Jasmin S., Levere T.E. Aging and cognition. Facilitation of recent memory in aged nonhuman primates by nimodipine Neurobiol. Aging. 11:1990;573-575.
27. Sansone M., Battaglia M., Vetulani J. Minaprine, but not oxiracetam, prevents desipramine-induced impairment of avoidance learning in mice. Pol. J. Pharmacol. 47:1995;69-73.
28. Sansone M., Castellano C., Ammassari-Teule M. Improvement of avoidance acquisition by the nootropic drug oxiracetam in mice. Arch. Int. Pharmacodyn. Ther. 275:1985;86-92.
29. Sansone M., Castellano C., Palazzesi S., Battaglia M., Ammassari-Teule M. Effects of oxiracetam, physostigmine, and their combination on active and passive avoidance learning in mice. Pharmacol. Biochem. Behav. 44:1993;451-453.
30. Sarter M., Hagan J., Dudchenko P. Behavioral screening for cognition enhancers. From indiscriminate to valid testing, Part I Psychopharmacology. 107:1992;144-159.
31. Sarter M., Hagan J., Dudchenko P. Behavioral screening for cognition enhancers. From indiscriminate to valid testing, Part II Psychopharmacology (Berlin). 107:1992;461-473.
32. Scriabine A., Schuurman T., Traber J. Pharmacological basis for the use of nimodipine in central nervous system disorders. FASEB J. 3:1989;1799-1809.
33. Thompson L.T., Deyo R.A., Disterhoft J.F. Nimodipine enhances spontaneous activity of hippocampal pyramidal neurons in aging rabbits at a dose that facilitates associative learning. Brain Res. 535:1990;119-130.
34. Vetulani J., Battaglia M., Castellano C., Sansone M. Facilitation of shuttle-box avoidance behaviour in mice treated with nifedipine in combination with amphetamine. Psychopharmacology (Berlin). 113:1993;217-221.
35. Vetulani J., Battaglia M., Sansone M. Nimodipine on shuttle-box avoidance learning in mice. No impairment but slight improvement Pharmacol. Biochem. Behav. 56:1997;577-581.
36. Wolthuis O.L. Behavioral effects of etiracetam in rats. Pharmacol. Biochem. Behav. 15:1981;247-255.